Aerovant: Phase IIb started

Aerovance began the double-blind, placebo-controlled, dose-ranging, U.S. and European Phase llb AeroTrial trial to evaluate 1, 3 or 10 mg of inhaled Aerovant given twice daily for 12 weeks in about 50...